Where it may be relevant
- Travellers visiting an area with a current outbreak or elevated chikungunya risk
- People whose itinerary or activities create substantial daytime mosquito exposure
- Long-stay travellers where individual risk justifies vaccination
Dose schedules.
The clinician will select the appropriate licensed schedule after reviewing age, health, previous doses and departure date.
Standard schedule
Eligible adults
A single dose; protection timing and any future booster need depend on current product guidance.
Who may be eligible
- Adults for whom the licensed product is age-appropriate and whose itinerary creates a meaningful risk
- Travellers assessed after destination, age, health and departure timing are reviewed
Who may not be eligible
- Anyone with a confirmed severe allergic reaction to a previous dose or a vaccine ingredient
- People who are acutely unwell with a significant fever may need vaccination deferred
- Pregnancy, breastfeeding, immune suppression and current medicines must be reviewed individually
- Age restrictions and precautions vary by product and must be checked before supply
Potential side effects
- Pain, redness or swelling where the injection is given
- Headache, tiredness, muscle aches or a mild fever
- Feeling faint around the time of vaccination
Important risks and precautions
- A severe allergic reaction is very rare and requires urgent treatment
- Protection is not absolute, so relevant food, water, bite or exposure precautions remain important
- The exact product and schedule must be confirmed during a clinical assessment
Clinical references
Further information.
- UKHSA Green Book
- TravelHealthPro country guidance
- https://www.gov.uk/government/collections/immunisation-against-infectious-disease-the-green-book
Information is general and does not replace a personal assessment, prescribing decision or the latest destination-specific advice.
